Zetta Genomics
Latest round
- Seed
Last raised
- Feb 2024
Total raised
- $11M
Investors
- 5
About Zetta Genomics
Established in 2018 and based in Cambridge, UK, Zetta Genomics Limited operates as a biotechnology company that provides data management solutions on genomic data technology and precision medicine. The company is a spinout from two genomic data pioneers, the University of Cambridge and Genomics England, and was founded by its CTO, Ignacio Medina. As of 2023, the company’s CEO is Mark Bailey. Zetta Genomics offers XetaBase, a cloud-based genomic data management platform that is built on the open-source CB (CellBase) platform and helps researchers and clinicians in the genomic, biomedical, and pharmaceutical industries analyze and manage genomic data. The firm’s data analytics platform enables users to aggregate and integrate more than 10TB of reference data from over 20 reference sources and store, retrieve, and annotate genotype data. The firm also offers web services, APIs for programming languages like R and Python, and an IVA web application dashboard tool for visualization.
Who invested in Zetta Genomics
5 investors across 4 rounds
See all investors in Zetta Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zetta Genomics
Who invested in Zetta Genomics?
Zetta Genomics has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zetta Genomics raised?
Zetta Genomics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Zetta Genomics last raise money?
Zetta Genomics's most recent round on record is a Seed, in Feb 2024.
What does Zetta Genomics do?
Established in 2018 and based in Cambridge, UK, Zetta Genomics Limited operates as a biotechnology company that provides data management solutions on genomic data technology and precision medicine.
Where is Zetta Genomics headquartered?
Zetta Genomics is headquartered in Cambridge, UK.
Which VCs invest in companies like Zetta Genomics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Zetta Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Zetta Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.